Kelly Financial Services LLC Purchases Shares of 2,000 The Clorox Company (NYSE:CLX)

Kelly Financial Services LLC purchased a new position in shares of The Clorox Company (NYSE:CLX) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 2,000 shares of the company’s stock, valued at approximately $325,000.

Other hedge funds have also recently modified their holdings of the company. State Street Corp raised its holdings in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after buying an additional 245,525 shares during the last quarter. Mizuho Securities USA LLC increased its position in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after acquiring an additional 4,490,421 shares during the period. Geode Capital Management LLC raised its stake in Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after acquiring an additional 33,970 shares during the last quarter. Stifel Financial Corp lifted its position in Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after acquiring an additional 37,967 shares during the period. Finally, Van ECK Associates Corp grew its stake in Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after purchasing an additional 31,510 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 0.1 %

Shares of NYSE:CLX opened at $160.31 on Friday. The firm has a market capitalization of $19.84 billion, a price-to-earnings ratio of 55.86, a price-to-earnings-growth ratio of 2.90 and a beta of 0.42. The business’s 50 day moving average price is $164.25 and its 200-day moving average price is $156.38. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company’s revenue was up 27.0% compared to the same quarter last year. During the same period last year, the firm posted $0.49 earnings per share. On average, equities research analysts forecast that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.04%. Clorox’s payout ratio is currently 170.04%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and lifted their target price for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a report on Thursday. Evercore ISI reduced their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Finally, Barclays dropped their target price on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Clorox presently has a consensus rating of “Hold” and a consensus price target of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.